Literature DB >> 27682363

Polyamine- and NADPH-dependent generation of ROS during Helicobacter pylori infection: A blessing in disguise.

Alain P Gobert1, Keith T Wilson2.   

Abstract

Helicobacter pylori is a Gram-negative bacterium that specifically colonizes the gastric ecological niche. During the infectious process, which results in diseases ranging from chronic gastritis to gastric cancer, the host response is characterized by the activation of the innate immunity of gastric epithelial cells and macrophages. These cells thus produce effector molecules such as reactive oxygen species (ROS) to counteract the infection. The generation of ROS in response to H. pylori involves two canonical pathways: 1) the NADPH-dependent reduction of molecular oxygen to generate O2•-, which can dismute to generate ROS; and 2) the back-conversion of the polyamine spermine into spermidine through the enzyme spermine oxidase, leading to H2O2 production. Although these products have the potential to affect the survival of bacteria, H. pylori has acquired numerous strategies to counteract their deleterious effects. Nonetheless, ROS-mediated oxidative DNA damage and mutations may participate in the adaptation of H. pylori to its ecological niche. Lastly, ROS have been shown to play a major role in the development of the inflammation and carcinogenesis. It is the purpose of this review to summarize the literature about the production of ROS during H. pylori infection and their role in this infectious gastric disease. Published by Elsevier Inc.

Entities:  

Keywords:  Gastric cancer; Helicobacter pylori; NADPH oxidase; Polyamines; Reactive oxygen species

Mesh:

Substances:

Year:  2016        PMID: 27682363      PMCID: PMC5366100          DOI: 10.1016/j.freeradbiomed.2016.09.024

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  131 in total

1.  Resistance to hydrogen peroxide in Helicobacter pylori: role of catalase (KatA) and Fur, and functional analysis of a novel gene product designated 'KatA-associated protein', KapA (HP0874).

Authors:  Andrew G Harris; Francis E Hinds; Anthony G Beckhouse; Tassia Kolesnikow; Stuart L Hazell
Journal:  Microbiology       Date:  2002-12       Impact factor: 2.777

Review 2.  Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes.

Authors:  R A Alm; T J Trust
Journal:  J Mol Med (Berl)       Date:  1999-12       Impact factor: 4.599

3.  Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines.

Authors:  Volaluck Supajatura; Hiroko Ushio; Akihiro Wada; Kinnosuke Yahiro; Ko Okumura; Hideoki Ogawa; Toshiya Hirayama; Chisei Ra
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

4.  J-Western forms of Helicobacter pylori cagA constitute a distinct phylogenetic group with a widespread geographic distribution.

Authors:  Stacy S Duncan; Pieter L Valk; Carrie L Shaffer; Seth R Bordenstein; Timothy L Cover
Journal:  J Bacteriol       Date:  2012-01-13       Impact factor: 3.490

5.  A paradigm for direct stress-induced mutation in prokaryotes.

Authors:  Josephine M Kang; Nicole M Iovine; Martin J Blaser
Journal:  FASEB J       Date:  2006-12       Impact factor: 5.191

6.  Escherichia coli expresses a copper- and zinc-containing superoxide dismutase.

Authors:  L T Benov; I Fridovich
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

7.  Comparative proteome analysis of Helicobacter pylori.

Authors:  P R Jungblut; D Bumann; G Haas; U Zimny-Arndt; P Holland; S Lamer; F Siejak; A Aebischer; T F Meyer
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

8.  Oxidative-stress resistance mutants of Helicobacter pylori.

Authors:  Adriana A Olczak; Jonathan W Olson; Robert J Maier
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

9.  Differential roles of ASK1 and TAK1 in Helicobacter pylori-induced cellular responses.

Authors:  Yoku Hayakawa; Yoshihiro Hirata; Hiroto Kinoshita; Kosuke Sakitani; Hayato Nakagawa; Wachiko Nakata; Ryota Takahashi; Kei Sakamoto; Shin Maeda; Kazuhiko Koike
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

10.  Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.

Authors:  Rupesh Chaturvedi; Mohammad Asim; M Blanca Piazuelo; Fang Yan; Daniel P Barry; Johanna Carolina Sierra; Alberto G Delgado; Salisha Hill; Robert A Casero; Luis E Bravo; Ricardo L Dominguez; Pelayo Correa; D Brent Polk; M Kay Washington; Kristie L Rose; Kevin L Schey; Douglas R Morgan; Richard M Peek; Keith T Wilson
Journal:  Gastroenterology       Date:  2014-02-13       Impact factor: 22.682

View more
  20 in total

1.  α-Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in Helicobacter pylori cagY.

Authors:  Johanna C Sierra; Giovanni Suarez; M Blanca Piazuelo; Paula B Luis; Dara R Baker; Judith Romero-Gallo; Daniel P Barry; Claus Schneider; Douglas R Morgan; Richard M Peek; Alain P Gobert; Keith T Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-25       Impact factor: 11.205

2.  Helicobacter pylori infection promotes Aquaporin 3 expression via the ROS-HIF-1α-AQP3-ROS loop in stomach mucosa: a potential novel mechanism for cancer pathogenesis.

Authors:  Jianfei Wen; Yao Wang; Cheng Gao; Guoxin Zhang; Qiang You; Weiming Zhang; Zhihong Zhang; Shoulin Wang; Guangyong Peng; Lizong Shen
Journal:  Oncogene       Date:  2018-03-22       Impact factor: 9.867

Review 3.  Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment.

Authors:  Linqi Zhu; Yue Huang; Hong Li; Shihe Shao
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-20       Impact factor: 4.813

4.  Siah2-GRP78 interaction regulates ROS and provides a proliferative advantage to Helicobacter pylori-infected gastric epithelial cancer cells.

Authors:  Pragyesh Dixit; Swathi Shivaram Suratkal; Shrikant Babanrao Kokate; Debashish Chakraborty; Indrajit Poirah; Supriya Samal; Niranjan Rout; Shivaram P Singh; Arup Sarkar; Asima Bhattacharyya
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

5.  Chitin Oligosaccharide (COS) Reduces Antibiotics Dose and Prevents Antibiotics-Caused Side Effects in Adolescent Idiopathic Scoliosis (AIS) Patients with Spinal Fusion Surgery.

Authors:  Yang Qu; Jinyu Xu; Haohan Zhou; Rongpeng Dong; Mingyang Kang; Jianwu Zhao
Journal:  Mar Drugs       Date:  2017-03-14       Impact factor: 5.118

6.  Distinct Immunomodulatory Effects of Spermine Oxidase in Colitis Induced by Epithelial Injury or Infection.

Authors:  Alain P Gobert; Nicole T Al-Greene; Kshipra Singh; Lori A Coburn; Johanna C Sierra; Thomas G Verriere; Paula B Luis; Claus Schneider; Mohammad Asim; Margaret M Allaman; Daniel P Barry; John L Cleveland; Christina E Destefano Shields; Robert A Casero; M Kay Washington; M Blanca Piazuelo; Keith T Wilson
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

Review 7.  Polyamines: Bio-Molecules with Diverse Functions in Plant and Human Health and Disease.

Authors:  Avtar K Handa; Tahira Fatima; Autar K Mattoo
Journal:  Front Chem       Date:  2018-02-05       Impact factor: 5.221

Review 8.  Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer.

Authors:  Salah A Sheweita; Awad S Alsamghan
Journal:  Mediators Inflamm       Date:  2020-07-08       Impact factor: 4.711

9.  Chronic Restraint Stress Induces Gastric Mucosal Inflammation with Enhanced Oxidative Stress in a Murine Model.

Authors:  Maimaiti Yisireyili; Aziguli Alimujiang; Aikebaier Aili; Yiliang Li; Salamaiti Yisireyili; Kelimu Abudureyimu
Journal:  Psychol Res Behav Manag       Date:  2020-05-04

10.  Astaxanthin Prevents Decreases in Superoxide Dismutase 2 Level and Superoxide Dismutase Activity in Helicobacter pylori-infected Gastric Epithelial Cells.

Authors:  Suhn Hyung Kim; Joo Weon Lim; Hyeyoung Kim
Journal:  J Cancer Prev       Date:  2019-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.